Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Inventory: 2018-2025

Historic Change in Inventory for Agios Pharmaceuticals (AGIO) over the last 6 years, with Sep 2025 value amounting to $1.2 million.

  • Agios Pharmaceuticals' Change in Inventory fell 52.41% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 38.78%. This contributed to the annual value of $8.5 million for FY2024, which is 19.31% down from last year.
  • As of Q3 2025, Agios Pharmaceuticals' Change in Inventory stood at $1.2 million, which was down 4.59% from $1.2 million recorded in Q2 2025.
  • Agios Pharmaceuticals' Change in Inventory's 5-year high stood at $4.3 million during Q2 2023, with a 5-year trough of $867,000 in Q2 2024.
  • For the 3-year period, Agios Pharmaceuticals' Change in Inventory averaged around $2.1 million, with its median value being $1.8 million (2023).
  • In the last 5 years, Agios Pharmaceuticals' Change in Inventory surged by 172.83% in 2023 and then tumbled by 79.82% in 2024.
  • Over the past 4 years, Agios Pharmaceuticals' Change in Inventory (Quarterly) stood at $3.3 million in 2022, then slumped by 45.66% to $1.8 million in 2023, then crashed by 34.13% to $1.2 million in 2024, then tumbled by 52.41% to $1.2 million in 2025.
  • Its Change in Inventory was $1.2 million in Q3 2025, compared to $1.2 million in Q2 2025 and $2.0 million in Q1 2025.